AFFECTIVE MODELS OF DEPRESSION AND ANXIETY IN PATIENTS WITH PARKINSON DISEASE AND MULTIPLE SCLEROSIS

According to the duration of the disease, the subjects were divided into two groups, the first group where the disease lasts 1-3 years and the second group where the disease lasts 4-5 years. According to the degree of disability, the participants with PB were divided into two groups: the first group (disease stages I and II) in which there were 29 participants (58%) and the second group (stage III-V) included 21 participants (42%) . According to the degree of anxiety, the participants were divided into two groups: the first group of participants with moderate anxiety (Hamilton score up to 17), the second group of participants with moderate and severe anxiety (Hamilton score 18-30). [...]they state that clinicians should test all patients with MS for anxiety and depression because they represent areas that can be treated in an MS patient [7].